Patents by Inventor Ana M. Calvo-Byrd

Ana M. Calvo-Byrd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9206458
    Abstract: Many fungal secondary metabolites are of industrial interest, such as antibiotics, while others are undesirable compounds such as mycotoxins. Overexpression of mtfA enhances production of fungal compounds with applications in the medical field, and overexpression or impaired mtfA expression decreases the production of compounds that negatively affect health/agriculture/economy such as mycotoxins.
    Type: Grant
    Filed: November 2, 2013
    Date of Patent: December 8, 2015
    Assignee: Board of Trustees of Northern Illinois University
    Inventors: Ana M. Calvo-Byrd, Vellaisamy Ramamoorthy
  • Patent number: 8927255
    Abstract: Many fungal secondary metabolites are of industrial interest, such as antibiotics, while others are undesirable compounds such as mycotoxins. Overexpression of mtfA enhances production of fungal compounds with applications in the medical field, and overexpression or impaired mtfA expression decreases the production of compounds that negatively affect health/agriculture/economy such as mycotoxins.
    Type: Grant
    Filed: November 1, 2013
    Date of Patent: January 6, 2015
    Assignee: Board of Trustees of Northern Illnois University
    Inventors: Ana M. Calvo-Byrd, Vellaisamy Ramamoorthy
  • Publication number: 20140134742
    Abstract: Many fungal secondary metabolites are of industrial interest, such as antibiotics, while others are undesirable compounds such as mycotoxins. Overexpression of mtfA enhances production of fungal compounds with applications in the medical field, and overexpression or impaired mtfA expression decreases the production of compounds that negatively affect health/agriculture/economy such as mycotoxins.
    Type: Application
    Filed: November 1, 2013
    Publication date: May 15, 2014
    Applicant: Board of Trustees of Northern Illinois University
    Inventors: Ana M. Calvo-Byrd, Vellaisamy Ramamoorthy
  • Publication number: 20140134671
    Abstract: Many fungal secondary metabolites are of industrial interest, such as antibiotics, while others are undesirable compounds such as mycotoxins. Overexpression of mtfA enhances production of fungal compounds with applications in the medical field, and overexpression or impaired mtfA expression decreases the production of compounds that negatively affect health/agriculture/economy such as mycotoxins.
    Type: Application
    Filed: November 2, 2013
    Publication date: May 15, 2014
    Applicant: Board of Trustees of Northern Illinois University
    Inventors: Ana M. Calvo-Byrd, Vellaisamy Ramamoorthy